Nasdaq · CIK 0001428336
HQY HEALTHEQUITY, INC.
Insider trading from SEC Form 4. Last filing Feb 12, 2025.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
9
with a Form 4 at this company
Signals
Open-market buys and sells at HEALTHEQUITY, INC., scored.
| Score | Side | Insider | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 0Weak | sell10b5-1 | SELANDER ROBERT W director | $640k | 5,750 | -7% | - | |
| 58Moderate | sell 4 | McCowan Debra Charlotte director | $478k | 5,000 | -39% | - | |
| 44Moderate | sell 4 | Rosner Elimelech EVP, CHIEF TECHNOLOGY OFFICER | $279k | 2,869 | -5% | - | |
| 75Notable | sell 4 | Parker Stuart B. director | $2.4M | 25,000 | -57% | - | |
| 23Weak | sell 410b5-1 | SELANDER ROBERT W director | $838k | 8,250 | -11% | - | |
| 23Weak | sell | Corvino Frank other | $100k | 1,039 | -22% | - | |
| 6Weak | sell10b5-1 | SELANDER ROBERT W director | $685k | 8,250 | -14% | - |
Congressional trades
7 trades in HQY disclosed by members of Congress under the STOCK Act. All congressional trades.
| Member | Type | Asset | Amount | Traded | Filed |
|---|---|---|---|---|---|
| Gilbert Ray Cisneros, Jr. House · D-CA | Purchase | HQY HealthEquity, Inc. - Common Stock | $1,001 to $15k | Jul 10, 2026 | 56 days after the trade |
| Gilbert Ray Cisneros, Jr. House · D-CA | Purchase | HQY HealthEquity, Inc. - Common Stock | $1,001 to $15k | Jun 30, 2026 | 2 days after the trade |
| Gilbert Ray Cisneros, Jr. House · D-CA | Purchase | HQY HealthEquity, Inc. - Common Stock | $1,001 to $15k | May 29, 2026 | 10 days after the trade |
| Lisa C. McClain House · R-MI | Purchase | HQY HealthEquity, Inc. - Common Stock | $1,001 to $15k | Jun 11, 2025 | 63 days after the trade |
| Lisa C. McClain House · R-MI | Sale | HQY HealthEquity, Inc. - Common Stock | $1,001 to $15k | Jun 17, 2025 | 57 days after the trade |
| Gilbert Ray Cisneros, Jr. House · D-CA | Partial sale | HQY HealthEquity, Inc. - Common Stock | $1,001 to $15k | Jun 16, 2025 | 24 days after the trade |
| Robert P. Bresnahan, Jr. House · R-PA | Sale | HQY HealthEquity, Inc. - Common Stock | $1,001 to $15k | Jan 13, 2025 | 31 days after the trade |
Transactions
The last 31 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 10, 2025 | SELANDER ROBERT W director | MOption exercise Common Stock10b5-1 | +12,500 | $28.68 | $359k | 83,969 | Feb 12, 2025 |
| Feb 10, 2025 | SELANDER ROBERT W director | SOpen-market sale Common Stock10b5-1 | -3,752 | $110.98 | $416k | 80,217 | Feb 12, 2025 |
| Feb 10, 2025 | SELANDER ROBERT W director | SOpen-market sale Common Stock10b5-1 | -1,998 | $111.87 | $224k | 78,219 | Feb 12, 2025 |
| Feb 10, 2025 | SELANDER ROBERT W director | MOption exercise Stock Option (right to buy)derivative10b5-1 | -12,500 | $0.00 | $0 | 12,500 | Feb 12, 2025 |
| Feb 3, 2025 | Parker Stuart B. director | AGrant or award Common Stock | +771 | $0.00 | $0 | 19,832 | Feb 5, 2025 |
| Feb 3, 2025 | Natarajan Rajesh director | AGrant or award Common Stock | +771 | $0.00 | $0 | 12,274 | Feb 5, 2025 |
| Jan 7, 2025 | Ladd Delano EVP, General Counsel | FTax withholding Common Stock | -475 | $97.54 | $46k | 63,502 | Jan 10, 2025 |
| Jan 7, 2025 | Lucania James M EVP & CFO | FTax withholding Common Stock | -1,848 | $97.54 | $180k | 76,295 | Jan 10, 2025 |
| Jan 7, 2025 | Neeleman Stephen FOUNDER AND VICE CHAIRMAN | FTax withholding Common Stock | -570 | $97.54 | $56k | 88,460 | Jan 10, 2025 |
| Jan 7, 2025 | Rosner Elimelech EVP, CHIEF TECHNOLOGY OFFICER | FTax withholding Common Stock | -1,707 | $97.54 | $167k | 55,488 | Jan 10, 2025 |
| Dec 12, 2024 | McCowan Debra Charlotte director | SOpen-market sale Common Stock | -5,000 | $95.56 | $478k | 7,779 | Dec 13, 2024 |
| Dec 12, 2024 | Rosner Elimelech EVP, CHIEF TECHNOLOGY OFFICER | SOpen-market sale Common Stock | -2,869 | $97.12 | $279k | 57,195 | Dec 13, 2024 |
| Dec 12, 2024 | Parker Stuart B. director | SOpen-market sale Common Stock | -24,272 | $96.70 | $2.3M | 19,789 | Dec 13, 2024 |
| Dec 12, 2024 | Parker Stuart B. director | SOpen-market sale Common Stock | -728 | $97.30 | $71k | 19,061 | Dec 13, 2024 |
| Dec 9, 2024 | SELANDER ROBERT W director | MOption exercise Common Stock10b5-1 | +12,500 | $28.68 | $359k | 72,219 | Dec 11, 2024 |
| Dec 9, 2024 | SELANDER ROBERT W director | SOpen-market sale Common Stock10b5-1 | -5,750 | $101.56 | $584k | 66,469 | Dec 11, 2024 |
| Dec 9, 2024 | SELANDER ROBERT W director | MOption exercise Common Stock10b5-1 | +7,500 | $21.27 | $160k | 73,969 | Dec 11, 2024 |
| Dec 9, 2024 | SELANDER ROBERT W director | SOpen-market sale Common Stock10b5-1 | -2,500 | $101.57 | $254k | 71,469 | Dec 11, 2024 |
| Dec 9, 2024 | SELANDER ROBERT W director | MOption exercise Stock Option (right to buy)derivative10b5-1 | -12,500 | $0.00 | $0 | 25,000 | Dec 11, 2024 |
| Dec 9, 2024 | SELANDER ROBERT W director | MOption exercise Stock Option (right to buy)derivative10b5-1 | -7,500 | $0.00 | $0 | 0 | Dec 11, 2024 |
| Nov 6, 2024 | Corvino Frank other | SOpen-market sale Common Stock | -1,039 | $96.10 | $100k | 3,784 | Nov 8, 2024 |
| Oct 9, 2024 | SELANDER ROBERT W director | MOption exercise Common Stock10b5-1 | +12,500 | $28.68 | $359k | 60,469 | Oct 11, 2024 |
| Oct 11, 2024 | Neeleman Stephen FOUNDER AND VICE CHAIRMAN | GGift Common Stockindirect: See footnote | -6,000 | $0.00 | $0 | 553,235 | Oct 11, 2024 |
| Oct 9, 2024 | SELANDER ROBERT W director | SOpen-market sale Common Stock10b5-1 | -1,504 | $82.07 | $123k | 58,965 | Oct 11, 2024 |
| Oct 9, 2024 | SELANDER ROBERT W director | SOpen-market sale Common Stock10b5-1 | -4,171 | $83.27 | $347k | 54,794 | Oct 11, 2024 |
| Oct 9, 2024 | SELANDER ROBERT W director | SOpen-market sale Common Stock10b5-1 | -75 | $83.77 | $6,283 | 54,719 | Oct 11, 2024 |
| Oct 9, 2024 | SELANDER ROBERT W director | MOption exercise Common Stock10b5-1 | +7,500 | $21.27 | $160k | 62,219 | Oct 11, 2024 |
| Oct 9, 2024 | SELANDER ROBERT W director | SOpen-market sale Common Stock10b5-1 | -752 | $82.27 | $62k | 61,467 | Oct 11, 2024 |
| Oct 9, 2024 | SELANDER ROBERT W director | SOpen-market sale Common Stock10b5-1 | -1,748 | $83.34 | $146k | 59,719 | Oct 11, 2024 |
| Oct 9, 2024 | SELANDER ROBERT W director | MOption exercise Stock Option (right to buy)derivative10b5-1 | -12,500 | $0.00 | $0 | 37,500 | Oct 11, 2024 |
| Oct 9, 2024 | SELANDER ROBERT W director | MOption exercise Stock Option (right to buy)derivative10b5-1 | -7,500 | $0.00 | $0 | 7,500 | Oct 11, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Corvino Frankother
- Ladd DelanoEVP, General Counsel
- Lucania James MEVP & CFO
- McCowan Debra Charlottedirector
- Natarajan Rajeshdirector
- Neeleman StephenFOUNDER AND VICE CHAIRMAN
- Parker Stuart B.director
- Rosner ElimelechEVP, CHIEF TECHNOLOGY OFFICER
- SELANDER ROBERT Wdirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.